How much is SAb Biotherapeutics worth in 2026?

SAb Biotherapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has SAb Biotherapeutics raised?

SAb Biotherapeutics has raised N/A in total funding across 2 funding rounds.

SAb Biotherapeutics

Drug Discovery

SAb Biotherapeutics valuation and funding history | Last updated: July 21, 2025 | 2 funding rounds

Current Valuation

N/A

As of July 21, 2025

Total Funding Raised

N/A

Across 2 rounds

Last Round

PIPE

$175.0M

Last Funding

Jul 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 21, 2025	PIPE	$175.0M	N/A	-
November 14, 2023	PIPE	$74.6M	N/A	-

Valuation Analysis

Current Valuation Metrics

SAb Biotherapeutics is currently valued at N/A as of July 21, 2025.

Track SAb Biotherapeutics Valuation Updates

Get notified when SAb Biotherapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for SAb Biotherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock SAb Biotherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is SAb Biotherapeutics Worth in 2026?

SAb Biotherapeutics is a leading private company in the Drug Discovery sector. Track SAb Biotherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How SAb Biotherapeutics Valuation is Determined

Private company valuations like SAb Biotherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.